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Background: This study aimed to systematically review the evidence from randomized controlled trials (RCTs) and to
conduct a meta-analysis of the effects of yoga on physical and psychosocial outcomes in cancer patients and survivors.
Methods: A systematic literature search in ten databases was conducted in November 2011. Studies were included if
they had an RCT design, focused on cancer patients or survivors, included physical postures in the yoga program,
compared yoga with a non-exercise or waitlist control group, and evaluated physical and/or psychosocial outcomes.
Two researchers independently rated the quality of the included RCTs, and high quality was defined as >50% of the
total possible score. Effect sizes (Cohen’s d) were calculated for outcomes studied in more than three studies among
patients with breast cancer using means and standard deviations of post-test scores of the intervention and control
groups.
Results: Sixteen publications of 13 RCTs met the inclusion criteria, of which one included patients with
lymphomas and the others focused on patients with breast cancer. The median quality score was 67%
(range: 22–89%). The included studies evaluated 23 physical and 20 psychosocial outcomes. Of the outcomes
studied in more than three studies among patients with breast cancer, we found large reductions in distress,
anxiety, and depression (d = −0.69 to −0.75), moderate reductions in fatigue (d = −0.51), moderate increases in
general quality of life, emotional function and social function (d = 0.33 to 0.49), and a small increase in functional
well-being (d = 0.31). Effects on physical function and sleep were small and not significant.
Conclusion: Yoga appeared to be a feasible intervention and beneficial effects on several physical and
psychosocial symptoms were reported. In patients with breast cancer, effect size on functional well-being was
small, and they were moderate to large for psychosocial outcomes.
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Cancer represents a major public health concern. In
Western countries, approximately one in three persons
will be directly affected by cancer before the age of
75 years, with breast cancer, melanoma, colorectal can-
cer and prostate cancer comprising the most common
types [1,2]. Due to medical advances, survival rates have* Correspondence: l.buffart@vumc.nl
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the 5-year survival rates across all cancers are app-
roximately 56% for male and 62% for female patients in
Australia [1] and 58% and 64%, respectively, in the
Netherlands [2]. However, cancer and its treatment are
often associated with prolonged adverse physical and psy-
chosocial symptoms, including reduced physical function
and fitness and increased risk of anxiety, depression, and
fatigue [3,4]. This greatly impacts the patient’s quality of
life (QoL) [5,6]. Therefore, there is a need for effective
methods to manage physical and psychosocial symptoms
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groups and cognitive behavioural therapies may help
patients cope with cancer and the psychosocial problems
associated with cancer and cancer treatment, but are less
likely to help with common physical issues such as loss
of strength and flexibility, weight gain, and reduced phys-
ical function [7]. Findings from previous reviews and
meta-analyses suggest that aerobic and resistance exer-
cise attenuate a range of the physical problems associated
with cancer and cancer treatment [3,4,6,8-16]. The bene-
fits of these types of exercise include not only improved
physical function, but also reduced fatigue and improved
QoL. Unfortunately, many cancer patients perceive vari-
ous barriers to exercise [17-21]. The most common phys-
ical barriers are physical discomfort and feeling sick.
Psychosocial barriers include having low mood, feelings of
self-consciousness relating to appearance and body image,
fatigue and fear for overdoing it [20,22,23]. Because of
these barriers, approximately one out of three adult cancer
patients turns to complementary and alternative medicine
techniques, mindfulness, or yoga, to help manage their
symptoms [24-26].
Yoga is a ‘mind-body’ exercise, a combination of phys-
ical poses with breathing and meditation [27]. Several
studies in the non-cancer population reported positive
effects of yoga on physical outcomes including perceptual
and motor skills [28], cardiopulmonary function [29], fit-
ness [30], muscle strength, flexibility, stiffness, and joint
pain [31-33]. Furthermore, a recent review of 10 studies
comparing the effects of yoga asanas (postures) with those
of ‘regular’ exercise, indicated that yoga may be as effect-
ive as exercise for improving health outcomes such as
blood glucose and lipids, fatigue, pain, and sleep in healthy
people and in people with conditions such as diabetes and
multiple sclerosis [34].
Previous reviews [35,36] and a meta-analysis [37] of
intervention studies have reported that yoga is feasible for
patients with cancer, with improved sleep, QoL, mood and
levels of stress. The current study extends previous work
by our exclusive focus on 1) randomised controlled trials
(RCTs), the most rigorous intervention study design; 2)
yoga interventions that included physical postures and
were not part of a larger program such as Mindfulness-
Based Stress Reduction; and 3) a focus on both physical
and psychosocial outcomes.
The aim of the present study is to conduct a system-
atic review and meta-analysis of the effects of yoga in
cancer patients and survivors, focusing on both physical
and psychosocial outcomes.
Methods
Literature search
IR, medical librarian, conducted the literature search in ten
databases: AgeLine and AMED (Allied and ComplementaryMedicine Database), British Nursing Index, CINAHL,
CENTRAL (The Cochrane Central Register of Controlled
Trials), EMBASE, PEDro, PsycINFO, PubMed and SPORT-
Discus (earliest to November 2011). In order to identify all
relevant papers, a search was conducted with both the-
saurus terms and free terms for ‘yoga’ in combination with
an extensive list of search terms to identify intervention
studies. RCTs were identified using search terms for certain
publication types (e.g. randomized controlled trial and con-
trolled clinical trial in PubMed) in combination with a list
of free text terms in title and abstracts that could be used
to describe RCTs (e.g. randomi*ed, randomly, trial, groups).
Detailed search profiles are available on request from IR.
Additional articles were identified by manually checking
the reference list of included papers.
Study inclusion criteria
Study inclusion criteria were: (i) design: RCT; (ii) popula-
tion: adults with any cancer diagnosis either during or post
treatment; (iii) intervention: yoga including physical pos-
tures (asanas); (iv) control group: non-exercise or wait-list;
(v) outcome: physical and psychosocial outcomes. Only
full-text articles written in English were included. Studies
that included yoga as part of a larger intervention program
(e.g., Mindfulness-Based Stress Reduction, meditation, or
pranayama (breathing control) only) were excluded.
Selection process and quality assessment
Titles and abstracts of the references were reviewed to
exclude articles out of scope (JvU). Full-text articles of
potentially relevant records were assessed for eligibility
by two independent reviewers (LB and JvU).
LB and JvU independently assessed the quality of the
included papers using a Delphi list developed by Verhagen
et al. [38], which consists of nine equally weighted qual-
ity criteria to assess different methodological aspects
(see below). This list has previously been used for the
evaluation of methodological quality in systematic
reviews of exercise programs [39-41]. Criteria have a
‘yes’ (=1), ‘no’ (=0) or ‘don’t know’ (=0) answer format.
Disagreements between the reviewers were discussed
and resolved, and in case of doubt, a third reviewer
(MC) was consulted. Authors were contacted for add-
itional information if it was not possible to score an item
based on the information provided in the paper. Items
scoring a “yes” contribute to the quality scores, ranging
from 0 to 9 points. Where outcomes were assessed by
self-report only, criterion 5 (blinding of the outcome as-
sessor) was not applicable, and studies could obtain a
maximum quality score of 8 points. A study was classified
as a low quality study if the quality score was lower than
50% of the maximum possible score [41].
Criteria considered for quality assessment according to
Verhagen et al. [38]
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2. Was the treatment allocation concealed?
3. Were the groups similar at baseline?
4. Were the eligibility criteria specified?
5. Was the outcome assessor blinded?
6. Was the yoga instructor blinded (i.e. unaware of the
study aim)?
7. Was the participant blinded?
8. Were point estimates and measures of variability
(between groups comparison) presented for the
primary outcomes?
9. Did the analysis include an intention-to-treat
analysis?
Data extraction
The following data were extracted by LB: (i) study popula-
tion; (ii) type, intensity, frequency and duration of inter-
vention, (iii) control group; (iv) outcome measures; and (v)
effects on physical and/or psychosocial outcomes.
Meta-analysis
Effect sizes were calculated (standardized mean differ-
ence d) for all individual studies by subtracting the aver-
age post-test score of the control group (Mc) from that
of the yoga intervention group (My) and dividing the re-
sult by the pooled standard deviations of the yoga inter-
vention group and the control groups (SDyc) [42]. An
effect size of 0.5 thus indicates that the mean of the ex-
perimental group is half a standard deviation larger than
the mean of the control group. Effect sizes of 0.56 to 1.2
are large, while effect sizes of 0.33 to 0.55 are moderate
and effect sizes of 0 to 0.32 are small [43].
For outcomes that were investigated in >3 studies, indi-
vidual effect sizes were pooled in Comprehensive Meta-
Analysis (CMA; version 2.2.046). Because only one study
did not include patients with breast cancer [44], the meta-
analyses was conducted on data from studies including
patients with breast cancer only. As we expected consider-
able heterogeneity, we calculated pooled effect sizes with
the random effects model. This model assumes that the
included studies are drawn from ‘populations’ of studies
that differ from each other systematically (heterogeneity).
In this model, the prevalence resulting from the included
studies not only differs because of the random error
within studies (fixed effects model), but also because of
true variation in prevalence from one study to the next.
We first tested the heterogeneity under the fixed model
using the statistics I2 and Q. I2 describes the variance be-
tween studies as a proportion of the total variance. A value
of 0% indicates no observed heterogeneity, and larger
values show increasing heterogeneity, with 25% as low,
50% as moderate, and 75% as high heterogeneity [45].
When P values of the Q are above 0.05, the total variance
is due to variance within studies and not to variancebetween studies. We ran the analyses on all studies and
with outliers excluded. Studies with extreme values of
which the 95% confidence interval had no overlap with
the 95% confidence interval of the pooled estimate were
considered as outliers.
Results
After removing duplicates, the literature searches yielded
a total of 1909 unique records. For 171 potentially rele-
vant records, we checked full text (Figure 1). The major-
ity of the studies (n = 79) were excluded because they
were not designed as a RCT. Of the records identified in
the database search, 15 records met the inclusion cri-
teria. We found one additional RCT [31] from the refer-
ence list of the review by Smith and Pukall [35]. Both
Vadiraja et al. [46-48] and Raghavendra et al. [49,50]
published more than one paper on the same RCT, each
describing different outcome measures and/or subpopu-
lations. Thus 16 papers [31,32,44,46-58] of 13 RCTs
were included in this systematic review. Details of the
populations, yoga interventions, and outcomes of the
included studies are presented in Tables 1, 2 and 3.
Quality assessment
Results of the methodological quality assessment are pre-
sented in Table 4. Median quality score was 67% (range
22–89%). All but one study [31] were of high quality. All
included studies used randomization. In all but one [31]
study treatment allocation was concealed, and groups
were comparable at baseline, or dissimilarities at baseline
were adequately adjusted for in the analyses. All studies
adequately specified the eligibility criteria of the study
population. The outcome assessor was blinded in five
papers [32,51,52,57,58], but this criterion was not applic-
able in the seven papers using self-reported outcomes only
[44,47,49,50,55]. In five papers [51,52,55-57], the yoga in-
structor was blinded as he or she was unaware of the
study aim. Participants were blinded in two papers [51,58];
Banerjee [51] informed us that their study was double
blinded. In four papers, point estimates and 95% confidence
intervals (CI) for between group differences were reported
[47,50,54,58]. One paper [44] reported 95% CI only, and
three papers [46,48,55] only presented effect sizes, without
95% CI. In nine papers [32,47,48,50,52-55,58], data were
analyzed on an intention-to-treat basis.
Study population
Details of the study populations are reported in Table 1.
Twelve studies included patients with breast cancer and
one study focused on patients with lymphomas [44]. Five
studies in patients with breast cancer studies took place
during cancer treatment: three studies (five papers
[46-48,51,55]) during radiotherapy, one study [31] during
hormone therapy, and one study (two papers, [49,50])
Figure 1 Flow chart.
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therapy. Five studies [32,52,56-58] focused on breast can-
cer survivors who had completed treatment, and two
studies [53,54] included patients and survivors both dur-
ing and after treatment. The study in patients with lymph-
omas included patients during and after active treatment
[44]. Sample sizes ranged from 18 to 128 patients, with
seven studies including less than 50 patients, and only one
study with more than 100 patients. Average age of the par-
ticipants ranged from 44 to 63 years. One study did not
report the age of the patients [50]. Eleven studies in pa-
tient with breast cancer included women only, one study
[52] in mainly breast cancer patients (85%) included 5%
men, and the study in lymphoma patients [44] included
39% men.
Yoga program
The content of the yoga programs is summarized in
Table 2. All included a supervised yoga program with
physical poses (yoga asanas), combined with breathing
techniques (pranayama) and relaxation or meditation
(savasana or dhanya).
All yoga classes were led by experienced yoga instruc-
tors. Median program duration was seven weeks with a
range of six weeks to six months. In the study by Rao
et al. [50], the program duration depended on the number
of chemotherapy cycles, which ranged from four to eight.
In this latter study, supervised sessions were conducted
for 30 min before chemotherapy once every ten days. Fur-
thermore, patients were provided with audiotapes of theexercises for home practice and asked to practice 1 h daily
for 6 days/week during intervals between chemotherapy
cycles [49]. In general, the number of classes per week
ranged from one to three, and home practice was encour-
aged in nine studies, supported by audio or videotapes.
Session duration ranged from 30 to 120 min; three studies
did not report the session duration [31,44,50].
In nine studies [31,32,44,52-57] the yoga program was
compared with a wait-list control group. In three studies
[46-51], the control group received supportive therapy
with education, counseling, or coping preparation. In
one study, the control group received health education
classes [58].
Effects
Tables 5 and 6 present an overview of the effects of yoga
on physical and psychosocial outcomes, respectively (for
details, see Table 3). Fourteen papers reported on both
physical and psychosocial outcomes, and two papers
reported on psychosocial outcomes only.
Physical outcomes
Twenty-three physical outcomes were examined in thir-
teen of the included papers (Table 5). In addition to self-
reported physical function and functional well-being,
outcomes included nine physical symptoms (e.g., pain,
nausea, and dyspnoea), nine measures of physical activity
and fitness, and three biological variables. However, ex-
cept for physical function, functional well being, and
pain, the outcomes were studied in only three studies or
Table 1 Description of study populations in alphabetical order of first author
Author, year Diagnosis; treatment number of participants (n); gender
(%women); mean age (sd) and/or
range
eligibility criteria
Banasik, 2011 [56] Breast cancer, (>2 mo) post-treatment n = 18 (9Y, 9C) % women: 100% Age:
62.9 (7.1) years
Inclusion women with stages II-IV breast cancer at least 2 months post-treatment.
Exclusion receiving Herceptin therapy, pregnant or lactating, had past or current history of
other neoplasm, active serious infection or immune deficiency; history of psychiatric disorders
or alcohol or drug abuse; steroid therapy or physical condition preventing yoga.
Banerjee, 2007 [51] Breast cancer, during radiotherapy n = 58 (35Y, 23C) % women: 100%
Age: 44 (1.3) years
Inclusion Recently operated breast cancer, age between 30 and 70 years, Zubrod’s
performance status 0–2 (ambulatory >50% of the time), high school education, treatment
plan of radiotherapy or both radiotherapy and chemotherapy, consent to participate in the
study.
Exclusion Having any concurrent medical condition likely to interfere with the treatment;
major psychiatric, neurological illness, or autoimmune disorders; cardiovascular illness; any
known metastases. No exposure to other mutagens, smoking or alcohol for at least 3 months
prior to pre-radiation blood donation.
Blank, 2003 [31] Breast cancer stage I-III receiving
antiestrogen or aromatase inhibitor
hormonal therapy
N = 18 (9Y, 9C) % women: 100% Age:
48 – 69 years
Inclusion minimum of eight weeks post chemotherapy, estrogen receptor positive status,
surgery for lumpectomy, modified mastectomy or full mastectomy (with/without
reconstruction), a life expectancy greater than six months, adequate blood cell counts and
kidney, liver, and cardiac function, physical and mental ability to attend all the Yoga training
sessions.
Exclusion women on Herceptin therapy, current steroid therapy, or other known
immunomodulating medications, pregnancy or current lactation, a past or current history of
another neoplasm, active serious infection or immune deficiency, documented alcohol or
drug abuse, history of psychiatric disorders requiring use of psychotropic medication.
Bower, 2012 [58] Breast cancer state 0 – II, at least
6 months after adjuvant cancer therapy.
n = 31 (16Y, 15C) % women: 100%
Age: 54.4 (5.7) years
Inclusion originally diagnosed with stage 0 to II breast cancer; completed local and/or
adjuvant cancer therapy (with the exception of hormone therapy) at least 6 months
previously; ages 40 to 65 years; postmenopausal; no other cancer in last 5 years; experiencing
persistent cancer-related fatigue.
Exclusion chronic medical conditions or regular use of medications associated with fatigue;
evidence that fatigue was driven primarily by a medical or psychiatric disorder other than
cancer; evidence that fatigue was driven primarily by other noncancer-related factors;
physical problems or conditions that could make yoga unsafe; a body mass index (BMI)
>31 kg/m2.
Carson, 2009 [32] Breast cancer; no current treatment (4.9
± 2.4 years since diagnose)
n = 37 (17Y, 20C) % women: 100%
Age: 54.4 (7.5) years
Inclusion Experiencing at least one hot flash per day on 4 or more days per week; no signs
of active breast cancer; no current cytotoxic chemotherapy; diagnosed with breast cancer at
stages IA-IIB ≥ 2 years before; no hormone replacement therapy currently or within prior
3 months; stabilized on constant regime of menopausal symptom medications and
supplements for at least 3 weeks; if taking antidepressants, stabilized at a fixed dose for at
least 3 months.
Exclusion resided≥ 70 miles from research site; unavailable to attend the intervention on the
day and at the time offered; currently engaged in intensive yoga practice (> 3 days/week);
having received treatment for serious psychiatric disorders (e.g. schizophrenia) in the previous
6 months; not English speaking
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Table 1 Description of study populations in alphabetical order of first author (Continued)
Chandwani, 2010 [55] Breast cancer, during radiotherapy N = 61 % women: 100% Age: 51.4
(8.0) range 37–68 years
Inclusion Women with stage 0-III breast cancer; ≥ 18 years; able to read, write and speak
English; scheduled to undergo radiotherapy.
Exclusion Patients who had any major psychiatric diagnosis or physical limitations that
would prohibit participation in the yoga program.
Cohen, 2004 [44] Lymphoma (18% Hodgkin), 61,5% active
treatment
n = 39 % women: 61.5% Age: 51 years Inclusion Patients with lymphoma who were either receiving chemotherapy or had received
it within the past 12 months; ≥ 18 years; able to read and speak English.
Exclusion Patients with major psychotic illnesses.
Culos-Reed, 2006 [52] Breast cancer (85%); no current
treatment (> 3 mo post-treatment)
n = 38 % women: 95% Age: 51.2
(10.3) years
Inclusion Cancer survivors who were currently not undergoing active treatment; no
additional health concerns; ≥ 18 years; minimum 3 months post-treatment.
Danhauer, 2009 [53] Breast cancer; 34% actively undergoing
treatment
n = 44 % women: 100% Age: 55.8
(9.9) years
Inclusion Women≥ 18 years; diagnosed with breast cancer; 2 to 24 months post-primary
treatment (surgery) following initial diagnosis and/or had a recurrence of breast cancer
within the past 24 months (regardless of treatment status); physically able to attend
restorative yoga; able to understand English; free of medical contraindications reported by
their physician.
Littman, 2011 [57] Breast cancer; > 3 mo post-treatment n = 63 % women: 100% Age: 60 (7.9)
years
Inclusion Age between 21 and 75 years; completion of breast cancer treatment (stage 0-III)
at least 3 months prior, BMI ≥24 kg/m2 (or ≥23 kg/m2 if of Asian descent).
Exclusion Myocardial infarction or stroke in the previous 6 months, diabetes, current yoga
practice, pregnancy or plans to become pregnant, factors that might lead to poor retention
and yoga practice.
Moadel, 2007 [54] Breast cancer; 48% medical treatment n = 128 % women: 100% Age: 54.8
(9.9) range 28–75 years
Inclusion Age≥ 18 years; new/recurrent breast cancer (stages I-III) diagnosis within previous
5 years; high performance status (Eastern Cooperative Oncology Group performance status
of < 3); ability to speak English or Spanish; not actively practicing yoga.
Raghavendra, 2007
[49]
Breast cancer, during chemotherapy n = 62 % women: 100% Age: n = 33
< 50 yrs; n = 29 > 50 yrs
Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 years;
Zubrod’s performance status 0–2; high school education; having a treatment plan with
surgery followed by adjuvant chemotherapy or by both adjuvant radiotherapy and
chemotherapy; consenting to participate in the study.
Exclusion history of intestinal obstruction and any known sensitivity to any class of
antiemetics.
Rao, 2009 [50] Breast cancer, during adjuvant
chemotherapy and radiotherapy
n = 98; % women: 100% Age: ? Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 years;
Zubrod’s performance status 0–2; high school education; having a treatment plan with
surgery followed by adjuvant radiotherapy and chemotherapy; consenting to participate in
the study.
Exclusion Having a concurrent medical condition likely to interfere with the treatment; any
major psychiatric, neurological illness or autoimmune disorders; secondary malignancy.
Vadiraja, 2009 [46-48] Breast cancer (stage II and III),
during adjuvant
n = 88; % women: 100% Age: 46 (9.1)
yrs yoga; 48.4 (10.2) yrs C.
Inclusion Recently diagnosed with operable breast cancer; aged between 30 and 70 years;
Zubrod’s performance status 0–2; high school education; having a treatment plan with
surgery followed by adjuvant chemotherapy or by both adjuvant radiotherapy and
chemotherapy; consenting to participate in the study.
Exclusion Having a concurrent medical condition likely to interfere with the treatment; any
major psychiatric, neurological illness or autoimmune disorders; any known metastases;
prescribed concurrent chemotherapy cycles during radiotherapy.
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Table 2 Description of yoga programs, in alphabetical order of first author and attendance to yoga class
Author, year Yoga program (Y); Duration and frequency (D); Home practice (H) vs comparison (C) Attendance
Banasik 2011 [56] Y Iyengar yoga given by expert Iyenger instructors, with focus on training and accepting the
physical form of the body without specific meditation component.
Average 14 classes out of 16 (87.5%), range 12 – 15.
D 8 weeks, twice a week, 90 min per session
H -
C wait-list
Banerjee, 2007 [51] Y Meditative practice, slow stretching and loosening exercises, motivation and counseling,
yoga asanas, group awareness practices, pranayama, deep relaxation
(yoga nidra) given by expert yoga trainers.
?
D 6-weeks; 90 min per session
H Patients were provided with audio and video tools to practice at home and were followed
up via telephone during weekends to ensure continuity of the practice.
C Supportive counseling and advised to take light exercise.
Blank, 2003 [31] Y Iyengar Yoga, including seated meditation, active asana, restorative poses, savasana. ?
D 8 weeks, 2 times per week
H 1 home practice per week
C wait-list control
Bower, 2012 [58] Y Iyengar yoga classes were taught by a certified Junior Intermediate Iyengar yoga instructor
and an assistant under the guidance of a senior teacher.
The mean number of yoga classes attended was 18.9 of 24 classes (78%), and
the median was 22 of 24 classes (92%).
D 12 weeks, twice a week, 90 min.
H -
C Health education classes were conducted for 120 min once a week for 12 weeks. Classes
were led by a PhD-level psychologist with clinical experience in the treatment of breast
cancer survivors.
Carson, 2009 [32] Y Yoga of Awareness given by certified yoga teacher: 40 min yoga poses, 10 min breathing
techniques, 25 min meditation, 20 min of study pertinent topics and 25 min group
discussion
Average 6 classes out of 8 (75%). 3 women less than 4 classes (3/17 = 17.6%)
D 8 weeks, once a week, 120 min
H Patients were encouraged to practice daily at home with aid of CD recordings and
illustrated hand books.
C Wait-list control
Chandwani, 2010 [55] Y The multidimensional yoga module was given a trained yoga instructor: 10 warm-up
movements synchronized with breathing, 25 min maintenance in selected postures, 10 min
deep relaxation, 5 min pranayama, 10 min mediation.
15 (50%) all 12 classes; 8 (28%) attended 11 classes; 1 (3%) attended
10 classes;
1 only 2 classes. One attended 3 classes, one 4, one 5, one 7 and one 8
classes. Average number of classes was 10.2 (85%); SD: 2.96; range 2 – 12.
Home practice:
8 (28%) reported practicing
D 6 weeks, 2 times per week; 60 min per session
H Patients were encouraged to practice type full yoga once per day outside the classes,
supported by a 60-min audio CD of the yoga program and a manual with photographs and
instructions.
C Wait-list control
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Table 2 Description of yoga programs, in alphabetical order of first author and attendance to yoga class (Continued)
Cohen, 2004 [44] Y Tibetan yoga sessions given by experienced instructor, divided into 4 aspects: controlled
breathing and visualization, mindfulness, and postures.
32% all sessions; 26% 5 or 6 sessions; 32% 2 or 3 sessions; 10% 1 session
D 7 weekly sessions
H Patients were encouraged to practice the techniques at least once per day, supported by
audiotape that walked them though all of the techniques.
C Wait-list control
Culos-Reed, 2006 [52] Y Classes were led by a certified yoga instructed and included 10 min gentle breathing;
50 min Yoga asanas; 15 min savasana.
D 7 weeks, 75 min.
H -
C Wait-list control
Danhauer, 2009 [53] Y Restorative yoga classes were taught by a yoga instructor with cancer-specific yoga
training and combined yoga asanas, pranayama, savasana.
Mean 5.8 (3.4) classes out of 10 (58%) 2 (10%) women 100%; 3 (14%) 0% of
classes
D 10 weekly 75-min classes
H -
C Wait-list control
Littman, 2011 [57] Y Viniyoga, a Hatha therapeutic type o f yoga given by certified experienced yoga
instructors: 5–10 min centering exercises to promote relaxation and internal focus,
50–60 min of seated and standing poses, 10–15 min guided relaxation, breathing exercises
and meditation.
Mean 19.6 (range 1–61; median 20.5) classes. Home practice: 55.8 times
(range 2 – 102; median 62).
D 6 months, 5 times per week including at least one 75-min class
H patients were given a DVD, VD and booklets of four home practices lasting 20–30 min
each.
C Wait-list control
Moadel, 2007 [54] Y Classes were given by a certified yoga instructor and included 3 yoga components:
physical stretches and poses, breathing exercises, and meditation.
High adherence (>6 classes): n = 33 (; Low adherence (1–6 classes), n = 24; No
adherence (0 classes), n = 27. Average attendance 7 out of 12 classes (58%).
D 12 weekly 1.5 hrs classes (more allowed)
H Patients were asked to practice yoga at home daily and given an audiotape/compact disk
for guidance.
C Wait-list control
Raghavendra, 2007 [49] Y Integrated yoga program administered by an instructor: asanas, breathing exercise,
pranayama, meditation and yogic relaxation techniques with imagery.
?
D 30 min before the start of the chemotherapy infusion (once in 10 days, number of cycles
4–8).
H Patients were provided with audiotapes of these exercises for home practice and asked to
practice daily for 1 h for 6 days/week during intervals between chemotherapy cycles.
C Supportive therapy and coping preparation
Rao, 2009 [50] Y Integrated yoga program administered by an instructor: asanas, breathing, pranayama,
mediation and yogic relaxation techniques with imagery.
?
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Table 2 Description of yoga programs, in alphabetical order of first author and attendance to yoga class (Continued)
D Four sessions during pre- and post operative period, 3 in-person sessions per week for
6 weeks during radiotherapy. During chemotherapy, subjects underwent person sessions
during their hospital visits for chemotherapy administration (once in 21 days) and an
additional yoga session once in 10 days.
H Patients were given booklets, audiotapes with instructions on practices for home practice.
C Supportive therapy sessions
Vadiraja, 2009 [46-48] Y Integrated yoga program administered by an instructor: asanas, breathing, pranayama,
mediation and yogic relaxation techniques with imagery.
29.7% attended 10-20% supervised sessions, 56.7% attended 20–25, 13.7%
attended >25 supervised sessions over a 6-week period. Attend minimal 3x/
wk for 6 weeks→ 18 classes.D Minimum of 3 in-person sessions per week for 6 weeks during radio treatment; 1 hour per
session. In total between 18–24 yoga sessions.
H Patients were given booklets, audiotapes with instructions on practices for home practice.
C Supportive therapy with education. 15-min counseling sessions once every 10 days during
6 weeks (3 or 4 sessions in total).
Asana = physical posture; Pranayama = breathing practice, voluntary regulated nostril breathing; Yoga nidra = deep relaxation; Savasana = the corpse pose, relaxation.
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Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of first author
Author, year Physical outcomes Between group difference Psychosocial outcomes Between group difference
Banasik, 2011 [56] FACT FACT
- Physical well-being N.S. - emotional well-being N.S.
- Functional well-being N.S. - social well-being N.S.
Cortisol, morning N.S. Breast cancer concerns N.S.
Cortison, noon P = 0.004 Fatigue P = 0.003
Cortisol, 5 p.m. P = 0.004
Cortisol, 10 p.m. N.S.
Banerjee, 2007 [51] DNA damage 14,5% less DNA damage in
Yoga group; p < 0.001
Anxiety (HADS-A) 48% reduction in yoga group vs 28%
increase in controls; p < 0.001
Depression (HADS-D) 57.5% decrease in yoga vs 24% decrease
in controls; p < 0.001
Perceived stress (PSS) 26.9% reduction in yoga vs 7% increase in
controls; p < 0.001
Blank, 2003 [31] 25% had relieved joint aches and
shoulder stiffness
NA 100% perceived direct stress reduction NA
88% felt more relaxed in daily life, more aware body
posture, improved body image
NA
63% had improved mood and less anxiety NA
Bower, 2012 [58] Lower extremity strength and
endurance (timed chair stands)
1.31 (−5.00; 2.38, N.S. Fatigue (FSI) −1.24 (−0.04; -2.45), p < 0.05
Flexibility (functional reach test) −2.00 (5.76; -9.98), N.S. Vigor 4.80 (1.86; 7.74), p < 0.05
Depression (BDI) −5.80 (−1.74; -9.86), p < 0.05
Sleep quality (PSQI) 0.20 (2.78; -2.38), N.S.
Perceived stress (PSS) −1.77 (1.71; -5.26), N.S.
Carson, 2009 [32] Hot flash frequency P = 0.0017 Negative mood P = 0.099
Hot flash severity P = 0.0019 Relaxation P = 0.543
Hot flash total P < 0.0001 Vigor P = 0.005
Joint pain P < 0.0001 Acceptance P = 0.058
Night sweats N.S. Symptom-related bother P < 0.0001
Fatigue P = 0.001
Sleep disturbance P = 0.007
Chandwani, 2010 [55] SF-36 SF-36
- Physical component summary ES = 0.44; P = 0.04 - Mental component summary N.S.
- Physical function ES = 0.46; p = 0.04 - Mental health N.S.
- body pain N.S. - Role physical N.S.
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Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of first author (Continued)
- Role emotional N.S.
- Social function N.S.
- vitality N.S.
- General HRQoL ES = 0,47; p = 0.005
Depression (CES-D) N.S.
Anxiety (STAI) N.S.
Distress (IES)
- Intrusion N.S.
- Avoidance N.S.
Fatigue (BFI) N.S.
Sleep (PSQI) N.S.
Benefit finding (BFS) N.S.
Cohen, 2004 [44] Distress (IES) N.S.
Anxiety (STAI) N.S.
Depression (CES-D) N.S.
Sleep disturbances (PSQI)
- Total score P = 0.004
- Sleep quality P = 0.02
- Sleep latency P = 0.01
- Sleep duration P = 0.03
- Sleep efficiency N.S.
- Sleep medications P = 0.02
- Daytime dysfunction N.S.
Fatigue (BFI) N.S.
Culos-Reed, 2006 [52] Physical activity (LSI) N.S. Mood (POMS)
Weight N.S. - Total mood P < 0.10
Systolic and diastolic blood pressure N.S. - Tension-anxiety P < 0.10
Hand grip strength N.S. - Depression-dejection P < 0.10
Distance walked N.S. - Confusion-bewilderment P < 0.10
Perceived exertion N.S. - Vigor N.S.
Flexibility (sit and reach) N.S. - Anger-hostility N.S.
EORTC-QLQ-C30 Symptoms of stress (SOSI)
- Physical function N.S. - Peripheral manifestations N.S.
- pain N.S. - Cardiopulmonary symptoms N.S.
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Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of first author (Continued)
- nausea and vomiting N.S. - Symptoms of arousal N.S.
- dyspnea P < 0.05 - Upper respiratory symptoms N.S.
- appetite N.S. - Central neurological symptoms N.S.
- constipation N.S. - Gastrointestinal symptoms P < 0.10
- diarrhea P < 0.05 - Muscle tension N.S.
- Habitual patterns N.S.
- Depression N.S.
- Anxiety/fear N.S.
- Emotional irritability P < 0.10
- Cognitive disorganization P < 0.10
HRQoL (EORTC QLQ-C30)
- global quality of life P < 0.01
- emotional function P < 0.05
- cognitive function N.S.
- social function N.S.
- role function N.S.
- fatigue (POMS) N.S.
- sleep disturbance N.S.
Danhauer, 2009 [53] Physical function (SF-12) N.S. Mental health (SF-12) P = 0.004
FACT Depression (CES-D) P = 0.026
- Physical well-being N.S. Fatigue (FACT-fatigue) N.S.
- Functional well-being N.S. Negative affect (PANAS-NA) P = 0.014
Positive affect (PANAS-PA) P = 0.01
FACT-General P = 0.052
- Social well-being N.S.
- Emotional well-being P = 0.042
Spiritual well being (FACIT Sp)
- peace/meaning P = 0.0009
- role of faith N.S.
Sleep disturbances (PSQI)
- Total score N.S.
- Sleep quality N.S.
- Sleep latency P = 0.078
- Sleep duration N.S.
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Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of first author (Continued)
- Sleep efficiency N.S.
- Sleep medications P = 0.10
- Daytime dysfunction N.S.
Littman, 2011 [57] FACT Overall QoL (FACT-G) N.S.
- Physical well-being N.S. Breast-cancer subscale N.S.
- Functional well-being N.S. - Social well-being N.S.
Physical Activity (MAQ) N.S. - Emotional well-being N.S.
BMI N.S. - social/family well-being N.S.
Waist circumference −3.1 (−5.7; -0.4) Fatigue (FACIT-F) N.S.
Hip circumference N.S.
weight N.S.
Moadel, 2007 [54] FACT Overall QoL (FACT-G) P < 0.01†
- Physical well-being N.S. - Social well-being ES = −0.22 (−3.78 to −0.36); P = 0.018
- Functional well-being N.S. - Emotional well-being P = 0.018*; P < 0.05†
Fatigue (FACT-fatigue) N.S.
Spiritual well-being (FACIT Sp) P = 0.009†
Distressed Mood (DMI) P < 0.05†
- Anxious/sad P = 0.046†
- Irritability P = 0.0275†
- Confusion N.S.
Raghavendra, 2007 [49] Nausea frequency P = 0.01 Anxiety (STAI) P < 0.001
Nausea severity P < 0.01 Depression (DBI) P < 0.001
Vomiting frequency P = 0.06 Number of distressful symptoms P = 0.002
Vomiting severity P = 0.05 Severity of symptoms P < 0.001
Total toxicity score P < 0.001 Symptom distress P < 0.001
Overall quality of life (FLIC) P < 0.001
Rao, 2009 [50] State anxiety (STAI) ES = 0.33; P < 0.05 (ITT)
Trait anxiety (STAI) ES = 0.24; NS (ITT)
Symptom distress P = 0.001
Vadiraja, 2009a [46] Cortisol level at 6 am ES = 0.24;P < 0.05 Anxiety (HADS-A) ES = 0.31; P < 0.001
Cortisol level at 9 am N.S. Depression (HADS-D) ES = 0.31; P < 0.01
Cortisol level at 9 pm N.S. perceived stress (PSS) ES = 0.36; P < 0.001
Mean pooled diurnal cortisol ES = 0.27; P < 0.05
Vadiraja, 2009b [47] EORTC QLQ-C30 Positive Affect (PANAS) ES = 0.59; P = 0.007
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Table 3 Description of physical and psychosocial outcomes and between group differences (yoga vs control), in alphabetical order of first author (Continued)
- Physical function ES = 0.16; N.S. Negative Affect (PANAS) ES = 0.84; P = 0.001
HRQoL (EORTC QLQ-C30)
- Role function ES = 0.19; N.S.
- Emotional function ES = 0.71; P = 0.001
- Cognitive function ES = 0.48; P = 0.03
- Social function ES = 0.21; N.S.
Vadiraja 2009c [48] Physical distress (RSCL) ES = 0.33; p = 0.02 Psychological distress (RCSL) ES = 0.39; p < 0.001
EORTC-QLQ-C30 EORTC QLQ-C30
- pain ES = 0.14; N.S. - fatigue ES = 0.33; N.S.
- nausea and vomiting ES = 0.05; N.S. - insomnia ES = 0.47; N.S.
- dyspnea ES = 0.01; N.S.
- appetite loss ES = 0.38; N.S.
- diarrhea ES = 0.01; N.S.
- constipation ES = 0.14; N.S.
Activity level ES = 0.14; N.S.
BDI = Beck’s Depression Inventory; BFI = Brief Fatigue Inventory; CES-D = Centers for Epidemiologic Studies-Depression; CT = chemotherapy; DMI = Distressed Mood Index; EORTC-QoL C30 = European Organization for
the Research and Treatment of Cancer-Quality of Life; ES = effect size; FACT-G = Functional Assessment of Cancer Therapy-General; FACIT = Functional Assessment of Chronic Illness Therapy; FLIC = Functional Living
Index for Cancer; FSI = Fatigue Symptom Inventory; HADS = Hospital Anxiety and Depression Scale; IES = Impact of Events Scale; ITT = Intention to treat; LSI = Leisure Score Index; MAQ =Modifiable Activity
Questionnaire; NA = not assessed; N.S. = not significant; PANAS = Positive and Negative Effect Schedule; POMS = Profile of Mood states; PSQI = Pittsburgh Sleep Quality Index; PSS = perceived stress scale;
RSCL = Rotterdam Symptom Check List; SOSI = Symptoms of Stress Inventory; STAI = Spielberger’s State Trait Anxiety Inventory.
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Table 4 Quality assessment sorted by study population and quality score
First author, year 1 2 3 4a 5 6 7 8 9 score %
Banasik, 2011 [56] Y Y Y Y SR Y C N N N 5 63%
Banerjee, 2007 [51] Y Y C Y Y Y Y C Y C N N 7 78%
Blank, 2003 [31] Y ? ? Y N ? N N N 2 22%
Bower, 2012 [58] Y Y Y Y Y ? Y Y Y 8 89%
Carson, 2009 [32] Y Y Y Y Y N C N N Y 6 67%
Chandwani, 2010 [55] Y Y C Y Y SR Y C N N, ES no CI Y 6 75%
Cohen, 2004 [44] Y Y Y Y NC (SR) N C N N, only 95% CI N 4 50%
Culos-Reed, 2006 [52] Y Y Y Y Y C Y C N N Y 7 78%
Danhauer, 2009 [53] Y Y Y Y NC N C N N Y 5 56%
Littman, 2011 [57] Y Y C Y Y Y C Y d N Y N 7 78%
Moadel, 2007 [54] Y Y C Y b Y NC N C N Y Y 6 67%
Raghavendra, 2007 [49] Y Y Y Y SR N N N N 4 50%
Rao, 2009 [50] Y Y Y Y SR N N Y Y 6 67%
Vadiraja, 2009a [46] Y Y Y Y ? ? N N, ES no CI N 4 50%
Vadiraja, 2009b [47] Y Y Y Y SR ? N Y Y 6 75%
Vadiraja, 2009c [48] Y Y Y Y SR ? N N, ES no CI Y 5 56%
NA not applicable, Y yes, N no, ? unclear, a If only exclusion criteria were reported, this was rated as ‘unclear’; b In the analyses, the baseline differences were
included as covariates. C after contacting authors; d Yoga instructors were aware that the study aim was to determine the feasibility of conducting a yoga
intervention in overweight and obese breast cancer survivors (not efficacy). SR self report, CI Confidence interval, ES effect size.
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draw conclusions on the effectiveness of yoga on these
outcomes. After excluding an outlier [55], the pooled ef-
fect size of yoga on physical function in patients with
breast cancer was small and insignificant (d = 0.17; 95%
CI = −0.06 to 0.40), see Table 7. Further, in patients with
breast cancer, yoga resulted in a small but significant in-
crease in functional well-being (d = 0.31; 95% CI = 0.04 to
0.58). Pain was evaluated in four studies, of which stand-
ard deviations to calculate effect sizes were not available
in two studies [32,44]. The average effect size of the other
two studies among patients with breast cancer [48,55] was
large (d = −0.64; 95% CI = −0.98 to −0.31).Psychosocial outcomes
Twenty psychosocial outcomes were examined in the fif-
teen included papers (Table 6). The effects of yoga on
distress, anxiety, depression, fatigue, sleep, general QoL,
emotional function and social function were evaluated in
three or more studies. After excluding outliers, yoga
resulted in significant large reductions in distress
(d = −0.75; 95% CI = −1.09 to −0.42), anxiety (d = −0.77;
95% CI = −1.08 to −0.46), and depression (d = −0.69; 95%
CI = −1.02 to −0.37), moderate reductions in fatigue
(d = −0.51; 95% CI = −0.79 to −0.22), and moderate
increases in general HRQoL (d = 0.37; 95% CI = 0.11 to
0.62), emotional function (d = 0.49; 95% CI = 0.16 to 0.81),
and social function (d = 0.33; 95% CI = 0.12 to 0.54) in
breast cancer patients, see Table 7. Effects on sleepdisturbances were small and insignificant (d = −0.26; 95%
CI = −0.53 to 0.02). In patients with lymphoma, however,
Cohen et al. [44] found a significant reduction in sleep dis-
turbances (d = −1.00; 95% CI = −3.8 to −0.8). Although
some studies found beneficial effects on other psycho-
social outcomes, including positive and negative effect,
mood, spirituality and relaxation (Table 6), these were
studied in less than three studies. Therefore, this evidence
was considered to be insufficient.Dropout and attendance
Dropout from the studies, defined as the number of ran-
domized participants without post-intervention meas-
urement ranged from 0 to 38%. Attendance at the yoga
classes was reported in nine studies [32,44,47,53-57], and
varied between 58 and 88% (Table 2). Vadiraja et al. [47]
reported that the level of adherence did not influence
results on QoL, positive and negative affect [47]. Four
other studies reported on the influence of intervention ad-
herence on outcomes. Danhauer et al. [53] reported that
better intervention adherence was associated with higher
self-reported physical function and QoL. In contrast,
Moadel et al. [54] found similar improvements in QoL
among participants with low and high class attendance,
but found a positive association between intervention at-
tendance and improved mood. Carson et al. [32] also
showed that greater mean yoga practice time was asso-
ciated with less fatigue, less symptom bother, and more ac-
ceptance at post-treatment, and tended to be associated
Table 5 Summary of the effects of yoga compared to control on physical outcomes
PHYSICAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Reference [56] [51] [31] [58] [32] [55] [44] [52] [53] [57] [54] [49] [50] [46] [47] [48]
Year 2011 2007 2003 2011 2009 2010 2004 2006 2009 2011 2007 2007 2009 2009a 2009b 2009c
Sample size 18 58 18 31 37 61 39 38 44 63 128 62 98 88 88 88
Treatment AT RT HT AT AT RT Mix AT Mix AT mix CT CT + RT RT RT RT
Quality high high low high high high high high high high high high high high high high
Physical function
Physical function N.S. ↑ N.S. N.S. N.S. N.S. N.S.
Functional well being N.S. N.S. N.S. N.S.
Physical symptoms
Pain ↓ N.S. N.S. N.S.
Nausea vomiting N.S. ↓ N.S.
Toxicity ↓
Diarrhoea ↓ N.S.
Constipation N.S. N.S.
Appetite N.S. N.S.
Dyspnea ↓ N.S
Hot flashes ↓
Night sweats N.S.
Activity/fitness
Physical Activity N.S. N.S. N.S.
Weight N.S. N.S.
Body mass index N.S.
Waist circumference ↓
Hip circumference N.S.
Flexibility N.S. N.S.
Strength N.S. N.S.
Fitness/distance walked N.S.
Perceived exertion N.S.
Biological Variables
DNA Damage ↓
Cortisol ↓ ↓
Blood pressure N.S.
↑ = increase after yoga compared to control; ↓ decrease after yoga compared to control; N.S. no significant differences between yoga and control
AT after treatment, CT chemotherapy, HT, hormonal therapy, RT radiotherapy, mix mixed group of patients during and after treatment.
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that generally, the benefits were greater among women
who attended more facility-based classes, but results were
not entirely consistent.
Safety
Five studies evaluated adverse events and provided this in-
formation in the manuscripts [47,50,53,57,58]. Four stud-
ies reported that there were no adverse events and one
study [58] reported one adverse event of a participant with
a history of back problems, who experienced a back spasm
in yoga class. After evaluation by her physician, she was
able to return to class and complete the intervention.Discussion
This review and meta-analysis described and evaluated
sixteen papers examining yoga as an intervention to
manage physical and psychosocial symptoms in cancer
patients and survivors. In contrast to previous reviews
[35,36] and meta-analysis [37] we only included studies
focusing on yoga interventions with physical postures,
and evaluating the effectiveness on physical and/or psy-
chosocial outcomes. Yoga appeared to be a feasible
intervention, and beneficial effects on several physical
and psychosocial symptoms were reported, with a small
effect on functional well-being and moderate to large
effects on various psychosocial outcomes.
Table 6 Summary of the effects of yoga compared to control on psychosocial outcomes
PSYCHOSOCIAL 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
Reference [56] [51] [31] [58] [32] [55] [44] [52] [53] [57] [54] [49] [50] [46] [47] [48]
Year 2011 2007 2003 2011 2009 2010 2004 2006 2009 2011 2007 2007 2009 2009a 2009b 2009c
Sample size 18 58 18 31 37 61 39 38 44 63 128 62 98 88 88 88
Treatment AT RT HT AT AT RT Mix AT Mix AT Mix CT CT + RT RT RT RT
Quality high high low high high high High high high high high high high high high high
Distress ↓ ↓ N.S. ↓ N.S. N.S. ↓ ↓ ↓ ↓
Anxiety ↓ ↓ N.S. N.S. ↓ ↓ ↓ ↓
Depression ↓ ↓ N.S. N.S. ↓ ↓ ↓ N.S.
Fatigue ↓ ↓ ↓ N.S. N.S. N.S. N.S. N.S.
Sleep disturbance N.S. ↓ N.S. ↓ N.S. ↓
General HRQoL ↑ ↑ ↑ ↑ N.S. ↑ ↑
Emotional function N.S. N.S. ↑ N.S. ↑ ↑
Social function N.S. N.S. N.S. N.S. N.S. ↑ N.S.
Role function N.S. N.S.
Cognitive function ↑
Positive affect ↑ ↑
Negative affect ↑ ↑
Vigor ↑ ↑
Mood ↑ ↑
Anger-hostility ↓
Spirituality ↑ ↑
Relaxation ↑ ↑
Confusion N.S.
Mental Health N.S. ↑
Acceptance ↑
↑ = increase after yoga compared to control; ↓ decrease after yoga compared to control; N.S. no significant differences between yoga and control
AT after treatment, CT chemotherapy, HT hormonal therapy, RT radiotherapy, mix, mixed group of patients during and after treatment.
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Due to the limited number of studies per physical out-
come, evidence for physical effects of yoga was generally
insufficient to draw firm conclusions. The effects of yoga
on physical function and functional well-being were
small. This may be related to the short intervention dur-
ation; only two studies lasted 12 weeks or longer [54,57],
all others were shorter, ranging from 6 to 10 weeks (me-
dian = 7). To improve physical function and fitness,
longer intervention duration may be required. The lack
of significant improvements in physical function and fit-
ness may also be related to the relatively low intensity of
certain types of yoga [52,59]. Nevertheless, in healthy
older adults, a 6-month yoga intervention resulted in
improved physical outcomes such as timed 1-leg stand,
flexibility, and energy [60]. These beneficial effects may
be related to the lower baseline cardiorespiratory fitness
of older adults compared with younger patients, and the
longer intervention duration in that specific study. Sig-
nificant improvements in treadmill time and estimated
peak oxygen uptake as a result of yoga have also been
shown in a small group of patients with chronic heartfailure [61]. A systematic review of studies comparing
yoga with other forms of exercise concluded that in both
healthy people and in patients with chronic diseases,
yoga may be as effective or better than other forms of
exercise at improving a variety of health-related outcome
measures, including physical outcomes such as muscle
strength and flexibility [34]. One study with healthy sed-
entary elderly people has reported that peak oxygen up-
take increased by 11% after yoga, compared with 24% after
aerobic training [62]. Although patients perceived that
they had improved fitness after 12 weeks of yoga [63], fu-
ture empirical evidence should indicate whether yoga is as
beneficial as endurance or strength exercise in improving
physical fitness in (physically inactive) cancer patients.
Psychosocial outcomes
This review found that yoga has large beneficial effects
on distress, anxiety and depression, moderate beneficial
effects on fatigue, general HRQoL, emotional function
and social function, and a small and insignificant effect
on sleep. There was insufficient evidence for effects on
psychosocial outcomes that were studied less frequently
Table 7 Pooled effects of yoga on physical and psychosocial outcomes in patients with breast cancer
Outcome # studies Pooled effect Test of heterogeneity
Physical outcomes d 95% CI Z P I2 Q P
Physical function 6 0.60 −0.05 to 1.25 1.81 0.07 87.51 40.03 <0.0001
5a 0.17 −0.06 to 0.40 1.48 0.14 0.00 1.20 0.88
Functional well-being 4 0.31 0.04 to 0.58 2.24 0.03 0.00 1.25 0.74
Psychosocial outcomes d 95% CI Z P I2 Q P
Distress 7 −0.95 −1.49 to −0.49 −4.04 <0.001 80.79 31.24 <0.001
6b −0.75 −1.09 to −0.42 −4.39 <0.001 59.59 12.37 0.03
Anxiety 7 −1.25 −1.93 to −0.56 −3.64 <0.001 91.45 70.20 <0.001
6b −0.77 −1.08 to −0.46 −4.86 <0.001 58.42 12.03 0.03
Depression 7 −1.47 −2.42 to −0.53 −3.05 0.002 93.29 89.46 <0.001
6b −0.69 −1.02 to −0.37 −4.21 <0.001 42.15 8.64 0.12
Fatigue 7 −0.51 −0.79 to −0.22 −3.46 0.001 43.52 10.62 0.10
Sleep disturbance 4 −0.26 −0.53 to 0.02 −1.82 0.07 0.00 1.25 0.74
General HRQoL 7 0.88 0.25 to 1.50 2.75 0.006 86.49 44.41 <0.001
6a 0.61 0.16 to 1.06 2.50 0.008 69.79 16.55 0.005
5a,c 0.37 0.11 to 0.62 2.85 0.004 0.00 3.40 0.49
Emotional function 5 0.49 0.16 to 0.81 2.93 0.003 26.58 5.45 0.24
Social function 6 0.33 0.12 to 0.54 3.12 0.002 0.00 1.94 0.86
a Excluding outlier Chandwani et al. 2010 [55]; b Excluding outlier Banerjee et al. [51]. c Excluding outlier Raghavendra et al. 2007 [49].
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ality, relaxation and mental health. More studies evaluat-
ing the effects of yoga on these outcomes are needed
before we can draw firm conclusions.
The finding that yoga improves QoL, and reduces dis-
tress and depression concurs with findings from previous
reviews and meta-analysis of yoga interventions for cancer
patients and survivors [35,37]. In contrast, the current
meta-analysis could not confirm previous findings on
reductions in sleep disturbances in patients with breast
cancer. Fatigue is among the most frequently occurring
and debilitating complaints associated with cancer and
cancer treatments [5,64]. Therefore, it is important to find
effective strategies to reduce fatigue in cancer patients. In
contrast to the meta-analysis of Lin et al. [37], we found a
moderate significant effect size on fatigue. This is in line
with a recent study of Bower et al. [58] who showed benefi-
cial effects after 12 weeks of yoga classes on persistent
fatigue in breast cancer survivors. In addition, patients
themselves also perceived improvements in QoL, fatigue,
stress, anxiety and depression [63]. The moderate-to-
large effect sizes on these psychosocial outcomes seem
larger than the small to moderate effect sizes of exercise
[12,16,65-67] or psychosocial interventions [12,66,68].
However, our results have to be interpreted with caution
due to small sample sizes in most studies. Furthermore ef-
fect sizes may also be influenced by patient selection, i.e.
including also non-fatigued or non-depressed patients.
Therefore, future studies should obtain insight in the mosteffective interventions to improve psychosocial outcomes.
The current meta-analysis showed that yoga may be such
an intervention.
Methodological quality of studies
This review included a quality rating, and only one paper
was of low quality. A major concern regarding the meth-
odological quality of most included studies was that not
all participants completed the yoga program and data
were not analysed on an intention-to-treat basis. This
may have introduced bias, overestimating the benefits of
yoga. Only half of the studies reported class attendance, of
which four studies indicated that intervention adherence
was positively associated with some outcomes [32,53,54,57].
Whether adherence to the yoga sessions was affected by
cancer-related symptoms or side-effects of cancer treat-
ment was not reported.
Most studies separately reported the descriptive results
of the outcomes for the yoga and control groups, and
presented only p-values for the group differences. Many
studies however, did not report effect sizes or other point
estimates of the between-group differences, and their con-
fidence intervals. Therefore we calculated standardized
mean differences using means and standard deviations of
the post-test values.
Furthermore, as with all exercise interventions, blinding
was difficult. Because the control group usually consisted
of either wait-list or usual care, participants were not
blinded to the intervention, possibly introducing bias.
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The extensive search in ten databases, the inclusion of
RCTs, the methodological quality assessment and con-
duction of a meta-analysis are strengths of the study.
Further, by only including studies focusing on yoga
interventions that contained physical postures (asanas),
we attempted to reduce the variability between the yoga
interventions, thereby increasing the comparability of
studies. Nevertheless, there may still remain some vari-
ability between the different types of yoga interventions
included in this review. This may be reflected by the high
heterogeneity. Other sources of high heterogeneity may be
differences in instruments used to define the outcome, dif-
ferences in patient groups (i.e. different stage of cancer, or
different timing of the intervention with respect to pri-
mary cancer treatment), or differences in control groups.
Because of the small number of studies, we were unable to
conduct subgroup analyses to further reduce heterogen-
eity. Although we used random effects modelling to take
into account the large heterogeneity, overall effect sizes
should be interpreted with caution as they may vary some-
what among subgroups.
In general, publication bias endangers the external valid-
ity of reviews and meta-analyses. Also in this study, publi-
cation bias cannot be ruled out. Another limitation is the
small sample size of some studies. In addition, some stud-
ies were conducted by the same research group, and other
studies had multiple outcomes, increasing the probability
of type 1 errors. Furthermore, most studies offered yoga to
people based on having cancer, not based on having phys-
ical or psychosocial problems, which may have resulted in
an underestimation of the beneficial effects of yoga.
The yoga interventions were conducted during various
forms of cancer treatment; some were conducted post-
treatment, and some studies included a mixed sample of
patients during and post-treatment. Due to the limited
number of studies, it is difficult to draw conclusions on
the optimal timing for yoga interventions. Future studies
should consider this issue.
Further, although effect sizes for many psychosocial out-
comes were generally moderate to large, effect sizes of
yoga interventions on physical function and functional
well-being were small. This may indicate that the effect is
small, or that some patients may have physical benefits
from yoga whereas others may not, which may be indica-
tive of the heterogeneity of cancer patients. Future studies
with large sample sizes should identify moderators of the
effect of yoga on physical and psychosocial outcomes in
order to identify subgroups of patients whom may specif-
ically benefit from yoga.
Finally, this review only included papers published in
the English language. Although our searches were not lim-
ited to language, we may have missed important findings
from yoga in Asia, in which practicing yoga is much morecommon than in Western countries. Nevertheless, this re-
view included six studies that were conducted in Asia.
Clinical implications
The emerging literature provides preliminary support for
the feasibility and efficacy of yoga interventions for cancer
patients. Only one adverse effect was reported in five stud-
ies that assessed adverse events, and the results indicate
that yoga may improve physical well-being and psycho-
social outcomes. Although the literature suggests yoga
may be effective in improving physical outcomes in other
patients and healthy elderly [29,30,34], evidence in cancer
patients and survivors is generally insufficient to draw firm
conclusions at this stage. In contrast, physical exercise has
been shown to be effective in improving physical function
and fitness in cancer patients and survivors [3,4,10,16].
However, for cancer patients and survivors who are unable
or unwilling to participate in traditional aerobic or resist-
ance exercise programs yoga may be an appropriate form
of exercise [63] as it is especially suitable for those who
perceive barriers to other forms of exercise [69]. Breast
cancer patients have been found to perceive more barriers
to exercise than age-matched controls, and higher barriers
were associated with less exercise [70]. In a recent pilot
study, breast cancer survivors reported minimal barriers
and high motivation for participating in a yoga program
[63]. All participants reported that yoga was beneficial and
enjoyable, that they were confident that they could do the
exercises, and that they were motivated to attend all
classes [63]. However, evidence for yoga as an effective
intervention to improve physical function and fitness is
lacking and should be established by future studies. Future
studies should also systematically assess and report ad-
verse events related to yoga.Conclusion
This systematic review and meta-analysis of RCTs showed
that yoga has strong beneficial effects on distress, anxiety
and depression, moderate effects on fatigue, general
HRQoL, emotional function and social function, small
effects on functional well-being, and no significant effects
on physical function and sleep disturbances. Results of the
current review must be interpreted with caution due to
the relative small sample sizes of most of the included
studies. RCTs with larger sample sizes are needed to im-
prove our understanding of the physical and psychosocial
effects of yoga. Future studies should also address the
optimal duration and frequency of yoga, the effects in
patients with types of cancer other than breast cancer, and
the optimal time point in the cancer and cancer treatment
or rehabilitation trajectories for offering yoga interven-
tions [63].
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